Remarkably, CWF19L1-overexpressing OT-I CTLs demonstrated significantly enhanced killing specificity against all three types of tumor cells compared to control OT-I CTLs (Fig. 7, A−D). The gene discussed is CWF19L1; the disease is neoplasm.